UTHR - Company ID 0001082554
UNITED THERAPEUTICS Corp (UTHR) reported revenue of $3.18B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $3.18B | +10.6% |
| FY 2024 | $2.88B | +23.6% |
| FY 2023 | $2.33B | +20.2% |
| FY 2022 | $1.94B | +14.9% |
| FY 2021 | $1.69B | +13.6% |
| FY 2020 | $1.48B | +2.4% |
| FY 2019 | $1.45B | -11.0% |
| FY 2018 | $1.63B | -5.7% |
| FY 2017 |
UNITED THERAPEUTICS Corp (UTHR) reported revenue of $3.18B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, UNITED THERAPEUTICS Corp's revenue grew from $743.18M to $3.18B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.73B |
| +7.9% |
| FY 2016 | $1.60B | +9.1% |
| FY 2015 | $1.47B | +13.8% |
| FY 2014 | $1.29B | +15.4% |
| FY 2013 | $1.12B | +21.9% |
| FY 2012 | $916.08M | +23.3% |
| FY 2011 | $743.18M | - |